Find Companies With New FDA Clearances

Overview

An FDA clearance or approval is a starting gun. The moment it lands, a company shifts from proving the product works to selling it — and that transition requires things they mostly don't have yet: a sales force, reimbursement and market access strategy, manufacturing scale-up, distribution, packaging, and marketing. For vendors and consultants serving life sciences, the approval date is the most predictable buying trigger in the industry.

This Hound watches FDA clearance and approval databases, filters for the companies whose launch you can support, finds the commercial or regulatory lead, and opens the conversation at the start of the launch window.

How to set it up

Four things to brief your Hound. This is the exact configuration behind this play.

A · Describe the opportunity

This is the brief every source is filtered against. You describe what you're looking for in plain language, add keywords to sharpen it, then set the structured criteria.

Tell Forest what you're looking for:

"I'm looking for companies that just received FDA clearance or approval and are about to commercialize — 510(k) clearances, PMA approvals, and drug approvals in my therapeutic or device categories. A clearance means they're about to need what I sell to launch. I want them right at approval, before the launch vendors are chosen. Prioritize smaller and first-time filers who don't have commercial infrastructure. Skip large pharma with full in-house commercial teams and categories I don't serve."

Keywords to watch for: 510(k) clearance · FDA approval · PMA approved · de novo · breakthrough designation · NDA approval · first commercial launch · [your device/therapeutic category] · [your service]

Fields to extract: company · product_name · submission_type · decision_date · product_code · device_class · indication · applicant_address · predicate_device

Match criteria:

• ✓ Product category matches what you support

• ✓ Company profile suggests thin commercial infrastructure (small, first-time filer)

• ✓ Recently cleared/approved (launch window is open)

• ✗ Exclude large pharma/device companies with full commercial teams

• ✗ Exclude categories outside your expertise

B · Choose the sources to monitor

FDA decisions are public and published in structured databases — free, and updated continuously.

FDA databases (free — connected by default) 🟢

• 510(k) Premarket Notification Database — accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm — Every device clearance: applicant, product code, decision date, indication.

• PMA Database — accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm — Premarket approvals for higher-risk devices.

• Drugs@FDA — accessdata.fda.gov/scripts/cder/daf — Drug approvals, labels, and application history.

• openFDA API — open.fda.gov — A free, public API across FDA datasets — the cleanest programmatic access to all of the above.

• FDA Press Announcements — fda.gov/news-events — Novel approvals and designations.

Firmographic context (built in) 🔌

• Crustdata (via Forest) — company size, headcount, and funding, so your brief can distinguish a 40-person startup with no sales force from a company that already has one. This is the qualifying filter for this play.

News & Press 🟡 default source, always on — reads the open web against your brief for approval coverage, launch announcements, and commercial-team hiring — often the clearest signal that a company is staffing up to sell.

C · Define the ICP to reach

Who to reach at the newly cleared company, in priority order, with fallbacks.

1. VP Commercial / Chief Commercial Officer — Primary — owns the launch — PRIMARY

2. VP Regulatory Affairs / Quality — Owns compliance-adjacent needs and knows the timeline

3. CEO / Founder — Fallback at small companies where the founder runs commercialization — FALLBACK

D · Email & LinkedIn sequence

The play the Hound runs for each match. Fields from the FDA record drop in as variables.

Email · Day 0 Congratulations on the {{submission_type}} for {{product_name}}. Clearance is the easy part — the launch is where most teams discover they need {{your_offering}} faster than they planned. We've supported {{product_category}} launches through exactly this stretch. Worth a short call while the plan is still being built?

↓ Wait 3 days · no reply

LinkedIn · connection request · Day 3 Hi {{first_name}} — congratulations on {{product_name}}'s clearance. Would value connecting.

↓ Wait 4 days · no reply

Email · Day 7 · follow-up Following up on {{product_name}} — happy to share what comparable {{product_category}} launches wish they'd started earlier, no obligation. Useful reference even if your launch plan is set.

⏸ Any reply on either channel pauses the whole sequence — the conversation is yours.